PTSD
Next step in MDMA trials for PTSD takes place in Vancouver and Montreal
Numinus Wellness Inc. will host the clinics for the extension of the MAPS study.
Canadian military veteran seeks legal access to psilocybin to heal wounds of war
Psychedelics company Field Trip supports Scott Atkinson’s request for exemption from Canada’s drug laws
U.K. research shows MDMA-assisted therapy can help people with severe PTSD
With MDMA, patients can revisit and process memories of traumatic experiences
Enhancer boosts psilocin potential in psychedelic therapy to treat PTSD
Canadian company NeuroPharm Inc. files application with the U.S. Patent and Trademark Office in connection with a psychedelic therapy.
MDMA shows potential in PTSD treatment; more research needed on other psychedelics
Australian researchers review the state of the evidence for using these drugs in the treatment of post-traumatic stress disorder
Growing body of research shows patients with addiction, PTSD, and depression can benefit from psychedelic substances
Numinus Wellness chief medical officer Dr. Evan Wood cautions that it’s not a cure for everybody—but trials have shown statistically significant results
Cusp of breakthrough: clinical trial data suggest efficacy of MDMA therapy for PTSD
Clinical trials of MDMA psychotherapy are going on at 15 sites in the U.S., Canada, and Israel